| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multimethods randomized trial found that plain language versions improved parents’ understanding of health recommendations
|
Elliott, Sarah A.
|
|
|
161 |
C |
p. 8-19
|
artikel
|
| 2 |
A novel framework for incorporating patient values and preferences in making guideline recommendations: guideline panel surveys
|
Zeng, Linan
|
|
|
161 |
C |
p. 164-172
|
artikel
|
| 3 |
Assessment highlights need for improvement in standards of development of core outcome sets for rare genetic diseases
|
Ciucă, Andrada
|
|
|
161 |
C |
p. 84-93
|
artikel
|
| 4 |
A structured approach to information retrieval improved identification of funding and researchers’ conflicts of interest in trials included in Cochrane reviews
|
Faltinsen, Erlend
|
|
|
161 |
C |
p. 104-115
|
artikel
|
| 5 |
Clinical practice guidelines for frailty vary in quality but guide primary health care: a systematic review
|
Si, Huaxin
|
|
|
161 |
C |
p. 28-38
|
artikel
|
| 6 |
Cluster randomized trials in nursing homes should better be planned as open-cohort than as closed-cohort
|
Poupin, Pierre
|
|
|
161 |
C |
p. 1-7
|
artikel
|
| 7 |
Credibility at stake: only two-thirds of randomized trials of nutrition interventions are registered and lack transparency in outcome and treatment effect definitions
|
Mello, Arthur T.
|
|
|
161 |
C |
p. 74-83
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
161 |
C |
p. IFC
|
artikel
|
| 9 |
Editors’ Choice: Reaching beyond the evidence in clinical guidelines and their recommendations to build engagement and trust in communities
|
Tovey, David
|
|
|
161 |
C |
p. A1-A2
|
artikel
|
| 10 |
Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study
|
Dewidar, Omar
|
|
|
161 |
C |
p. 116-126
|
artikel
|
| 11 |
Guidance needed: where should randomized studies which do not assess a health outcome be registered?
|
Speich, Benjamin
|
|
|
161 |
C |
p. 183-184
|
artikel
|
| 12 |
Heterogeneous methodology in the development of patient versions of clinical practice guidelines: a scoping review
|
Meyer, Nora
|
|
|
161 |
C |
p. 53-64
|
artikel
|
| 13 |
Key concepts in clinical epidemiology: collider-conditioning bias
|
Digitale, Jean C.
|
|
|
161 |
C |
p. 152-156
|
artikel
|
| 14 |
Limited online training opportunities exist for scholarly peer reviewers
|
Willis, Jessie V.
|
|
|
161 |
C |
p. 65-73
|
artikel
|
| 15 |
Meta-research studies on reporting should transparently report core elements of data collection and results: authors' reply
|
Dal Santo, Tiffany
|
|
|
161 |
C |
p. 182-183
|
artikel
|
| 16 |
Noninferiority margins exceed superiority effect estimates for mortality in cardiovascular trials in high-impact journals
|
Ofori, Sandra
|
|
|
161 |
C |
p. 20-27
|
artikel
|
| 17 |
Poor handling of continuous predictors in clinical prediction models using logistic regression: a systematic review
|
Ma, Jie
|
|
|
161 |
C |
p. 140-151
|
artikel
|
| 18 |
Qualitative study of guideline panelists: innovative surveys provided valuable insights regarding patient values and preferences
|
Zeng, Linan
|
|
|
161 |
C |
p. 173-180
|
artikel
|
| 19 |
Reverse causation biases weighted cumulative exposure model estimates, but can be investigated in sensitivity analyses
|
Agay, Nirit
|
|
|
161 |
C |
p. 46-52
|
artikel
|
| 20 |
Revisiting ethnic discrepancies in COVID-19 hospitalized cohorts: a correction for collider bias
|
Learoyd, Annastazia E.
|
|
|
161 |
C |
p. 94-103
|
artikel
|
| 21 |
Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review
|
Crocker, Thomas Frederick
|
|
|
161 |
C |
p. 39-45
|
artikel
|
| 22 |
Should we expect meta-research studies to be perfectly conducted and reported? Response to Thombs et al.
|
Puljak, Livia
|
|
|
161 |
C |
p. 181-182
|
artikel
|
| 23 |
Systematic review finds risk of bias and applicability concerns for models predicting central line-associated bloodstream infection
|
Gao, Shan
|
|
|
161 |
C |
p. 127-139
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
161 |
C |
p. ii-v
|
artikel
|
| 25 |
Using the phases of clinical development of medicines to describe clinical trials assessing other interventions is widespread but not useful
|
Dal-Ré, Rafael
|
|
|
161 |
C |
p. 157-163
|
artikel
|
Tijdschrift beschrijving